Sinovac Biotech Ltd (SVA): Total Assets
$8.54B
As of 2025-12-31
-15.2%
3-year compound annual growth
+35.1%
5-year compound annual growth
+45.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.54B | -30.8% | 2026-06-05, Balance as of period end |
| 2024-12-31 | $12.34B | -9.4% | 2026-06-05, Balance as of period end |
| 2023-12-31 | $13.61B | -3.0% | 2026-04-30, Balance as of period end |
| 2022-12-31 | $14.03B | -16.3% | 2026-04-30, Balance as of period end |
| 2021-12-31 | $16.76B | +781.4% | 2026-04-30, Balance as of period end |
| 2020-12-31 | $1.90B | +320.4% | 2022-04-29, Balance as of period end |
| 2019-12-31 | $452.30M | +22.3% | 2021-04-22, Balance as of period end |
| 2018-12-31 | $369.78M | +23.6% | 2020-04-30, Balance as of period end |
| 2017-12-31 | $299.22M | +41.6% | 2019-04-29, Balance as of period end |
| 2016-12-31 | $211.35M | +4.2% | 2018-05-11, Balance as of period end |
| 2015-12-31 | $202.93M | -14.9% | 2017-11-22, Balance as of period end |
| 2014-12-31 | $238.53M | -0.9% | 2016-04-25, Balance as of period end |
| 2013-12-31 | $240.69M | +15.3% | 2015-04-29, Balance as of period end |
| 2012-12-31 | $208.76M | -3.3% | 2014-04-16, Balance as of period end |
| 2011-12-31 | $215.91M | +0.7% | 2013-05-23, Balance as of period end |
| 2010-12-31 | $214.36M | n/a | 2012-04-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $8.54B | -30.8% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $432.97M | +24.1% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $501.60M | +15.1% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.64B | +25.7% |
| MannKind Corp (MNKD) | 2025-12-31 | $792.18M | +101.1% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $1.17B | -1.1% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $826.14M | +595.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $261.15M | +8.4% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $605.19M | +1.9% |
Compare SVA, ARQT, ARDX, INVA side by side · Screen every company in Pharmaceutical Preparations ↗